Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2017-07-14 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（刘文君）
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate, Liu Wenjun, confirming qualifications, independence, and compliance with relevant laws and regulations for serving as an independent director of a company. It contains no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filings in the typical sense. It is a formal declaration related to board/management information, specifically about a director candidate's qualifications and independence. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a standalone declaration by a board candidate.
2017-07-14 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It outlines the principles, scope, definitions, and procedures for managing related party transactions within the company, including disclosure requirements, approval processes, and governance related to such transactions. There are no financial statements, earnings data, or direct financial results presented. The document is a governance policy document detailing internal rules and procedures for related party transactions, which falls under governance information rather than a financial report or announcement. It is not a report publication announcement or a regulatory filing as it is a substantive policy document. Therefore, the most appropriate classification is Governance Information (CGR).
2017-07-14 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled as "股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting" of the company. It details the rules, procedures, and regulations governing the convening, proposal submission, notification, and conduct of shareholders' meetings. It does not contain financial statements, audit opinions, voting results, or announcements of meetings, but rather the internal governance rules related to shareholder meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is over 6000 characters, indicating it is a full report rather than a brief announcement. Therefore, the appropriate classification is CGR with high confidence.
2017-07-14 Chinese
股东、董事、监事和高级管理人员所持公司股份及变动管理细则
Governance Information Classification · 95% confidence The document is a detailed internal regulation titled 'Shareholding and Change Management Rules for Shareholders, Directors, Supervisors, and Senior Management' of a company. It outlines rules and restrictions on shareholding, share transfers, and disclosure obligations for company insiders. It references relevant laws and stock exchange rules but does not contain financial statements, audit opinions, earnings data, or meeting materials. It is a governance-related document focused on internal rules and compliance regarding shareholding and trading by insiders. Therefore, it fits best under Governance Information (CGR). The document length (4820 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive governance policy document.
2017-07-14 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is a detailed set of rules and procedures for the Board Nomination Committee of a company, covering governance structure, committee composition, responsibilities, meeting procedures, and conflict of interest policies. It does not contain financial data, audit information, or announcements related to financial results or capital changes. It is a governance-related document outlining internal rules and practices of the board and its committees. Therefore, it fits the category of Governance Information (CGR). The document length is 3805 characters, which is sufficient for a detailed governance report rather than a brief announcement.
2017-07-14 Chinese
独立董事关于子公司上海执诚生物科技有限公司收购河南执诚起凡生物科技有限公司49%股权的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent opinion from the independent directors regarding a subsidiary's acquisition of a 49% equity stake in another company. It references the board meeting where the transaction was approved and confirms the fairness and legality of the transaction. The content is focused on governance and approval of a corporate transaction rather than financial results, audit, or regulatory filings. It is not a full report but an opinion related to a board decision on a capital transaction. This fits best under Capital/Financing Update (CAP) as it concerns an acquisition and equity stake transaction.
2017-07-07 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.